Zurueck zur Suche

Reporte zur Charge BNT162B2

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

69Reporte angezeigt
3Todesfaelle
8Hospitalisiert
2Lebensbedrohlich
1Bleibende Schaeden
FL 4 NY 4 VA 3 IL 3 CA 3 OH 2 IN 2 TX 2 MT 1 WY 1 KS 1 SC 1

VAERS 1804195

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

kritisch
Staat
VA
Alter
61,0
Geschlecht
M
Eingang
09.08.2022
Impfdatum
08.10.2021
Beginn
18.10.2021
Tage bis Beginn
10,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Angiogram cerebral abnormal Aphasia Arteriogram carotid normal Blood cholesterol normal Blood creatinine normal Asthenia Cerebrovascular accident Blood electrolytes normal Blood glucose normal Blood triglycerides normal Cerebral artery occlusion Investigation Loss of personal independence in daily activities Mutism Full blood count normal Gait disturbance Glycosylated haemoglobin increased High density lipoprotein decreased

Symptomtext

stroke; can't talk; can't talk or work and something with doing else next with for your life my talk on my rest my life; The initial case was missing the following minimum criteria: This case has been considered invalid as Unspecified product. Upon receipt of follow-up information on 02Aug2022, this case now contains all required information to be considered as valid. This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 61-year-old male patient received BNT162b2 (BNT162B2), on 08Oct2021 at 15:31 as dose number unknown, single (Lot number: 30135BA, Expiration Date: 30Nov2021) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUTISM (hospitalization) with onset 18Oct2021, outcome "not recovered", described as "can't talk"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (hospitalization) with onset 18Oct2021, outcome "not recovered", described as "can't talk or work and something with doing else next with for your life my talk on my rest my life"; CEREBROVASCULAR ACCIDENT (hospitalization, medically significant) with onset 18Oct2021, outcome "not recovered", described as "stroke". The patient underwent the following laboratory tests and procedures: Investigation: unknown, notes: heart monitor for the stroke. Therapeutic measures were taken as a result of cerebrovascular accident, mutism, loss of personal independence in daily activities. Clinical course: No any additional vaccines administered on same date of the Pfizer suspect. No any other vaccine taken prior vaccination within 4 weeks. Patient's medical history: No. Patient was stroke I ruined my life. It was grammatical but I the stroke. Follow-up (02Aug2022): The initial case was missing the following minimum criteria: This case has been considered invalid as Unspecified product. Upon receipt of follow-up information on 02Aug2022, this case now contains all required information to be considered as valid. Updated Information: Patient address updated, product information updated, VAERS Primary Reporter Addl Qualification updated as patient, lab data, patient age recalculated, outcome of event, treatment received, event onset date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Test Name: Investigation; Result Unstructured Data: Test Result:unknown; Comments: heart monitor for the stroke
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1578498

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT-162B2

kritisch
Staat
FL
Alter
63,0
Geschlecht
F
Eingang
17.08.2021
Impfdatum
04.03.2021
Beginn
24.07.2021
Tage bis Beginn
142,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

DEATH

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
14,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1958815

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT-162b2

schwer
Staat
PA
Alter
89,0
Geschlecht
M
Eingang
17.12.2021
Impfdatum
13.12.2021
Beginn
14.12.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anion gap Atelectasis Blood creatinine increased Blood lactic acid Blood urea increased Chest X-ray abnormal Hypoxia Laboratory test abnormal Muscle twitching N-terminal prohormone brain natriuretic peptide increased Pulmonary oedema Renal impairment Troponin Unresponsive to stimuli

Symptomtext

0430 12/14/21 Patient found with O2 sats in 70s, patient placed on 2L NC and NRB. Sats continued in the 80s, not responding to voice nor sternal rub. C/V: rapid rate. No murmur. Resp: CTA without wheeze, rales or rhonchi. Abd: soft to palpitation. Ext: No edema. Hands and feet at times were twitching. A/P hypoxemia with unresponsiveness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary oedema
Hospital-Tage
-
Labordaten
Temp 37.7, HR 104, RR 20, BP 115/60, O2 sats 86% on 15L NRB. CXR showed mild interstitial edema, left retrocardiac atelectasis Lactic acid 2.9 BUN 74 Cr 3.99 - worsening Anion gap 18 Trop 0.077 BNP pro increased to 2372 Labs show worsening renal and potentially worsening heart failure.
Aktuelle Erkrankungen
Dementia with recurrent agitation
Vorgeschichte
Bladder cancer status post cystectomy/prostatectomy, left nephroureterectomy with ileal conduit, CKD stage IIIb, chronic lower extremity edema, Asthma/COPD
Andere Medikamente
olanzapine, escitalopram, furosemide, melatonin, albuterol, guaifenesin, ipratropium, ondansetron, acetaminophen
Allergien
albuterol, anabolic, steroids
Vorherige Impfungen
-

VAERS 1909921

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

schwer
Staat
-
Alter
22,0
Geschlecht
F
Eingang
30.11.2021
Impfdatum
05.08.2021
Beginn
06.08.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anxiety Blood test Chest pain Computerised tomogram abnormal Condition aggravated Dyspnoea Electrocardiogram Flank pain Hypoaesthesia Muscle spasms Neck pain Pain Paraesthesia Pulmonary thrombosis Ultrasound scan X-ray

Symptomtext

Dizziness, cramping, confusion, shortness of breath immediately after the first dose and carried on for weeks after. Second dose on october 5th and days later I was super short of breath and had weird tingling in my legs and mostly my right leg/ right calf/ foot. Progressed into worsening of shortness of breath over the next few weeks. I ended up having left side pains and was dismissed and told all of these symptoms were anxiety. The left side pain got worse and came to the point where breathing hurt or sniffling my nose hurt. The next day I tried to lay down and the pain shot up into my neck, a dull ache. I then went to emergency where they took blood, ecg, x-rays, ultra sound, and a ct scan. ( november 7th) They came back with the results that I have blood clots in my lungs. Since this finding I have been in and out of emergency with severe spasms, pains, tingling and numbness like feelings and pain in my side and chest.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
-
Labordaten
November 7th - ct scan showed blood clots In and out for blood work and to get checked on for reoccurring pains Unknown dates prior to the finding of emergency visits oh blood work and being looked at.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
BCP on and off
Allergien
Lactose
Vorherige Impfungen
-

VAERS 1773463

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

schwer
Staat
AZ
Alter
60,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
23.09.2021
Beginn
23.09.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood potassium decreased Blood pressure increased Condition aggravated Feeling abnormal Headache Heart rate irregular Muscular weakness Paralysis Somnolence

Symptomtext

Blood pressure to 185/109 within 10 minutes. Potassium level (serum) drop. Pulse at 51 bpm. Typical BP is 110 / 75. Followed over course of 48 hours with extreme muscle weakness and near flaccid paralysis, irregular heartbeat and gripping headache (not a common occurrence for me) with "brain fog"; slept approximately 16 hours over the next 36. Second reaction better than first dose because we prepared better based on first reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paralysis
Hospital-Tage
-
Labordaten
BP check at PCP's office next door to pharmacy. Clonidine given to reduce blood pressure as quickly as possible. Given approximately 20 minutes after shot on 10-23-21.
Aktuelle Erkrankungen
-
Vorgeschichte
Hypokalemic Periodic Paralysis Disorder with potential Andersen-Tawil Syndrome
Andere Medikamente
Potassium as Ultima Replenisher (electrolyte powder formula); B-12 (vegan); Vit D (Vegan); Artichoke leaf
Allergien
Penicillin and all related antibiotics Cats Fabreze
Vorherige Impfungen
COVID Pfizer, 1st dose - similar to first but worse - BP to 193 / 132 within 5 minutes; severe muscle weakness, Potassium shift,

VAERS 1578507

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT-162B2

schwer
Staat
FL
Alter
78,0
Geschlecht
M
Eingang
17.08.2021
Impfdatum
03.03.2021
Beginn
27.07.2021
Tage bis Beginn
146,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Chest X-ray Dyspnoea Exposure to SARS-CoV-2 Intensive care Pyrexia SARS-CoV-2 test

Symptomtext

SHORT OF BREATH, EXPOSURE TO WIFE WITH covid, FEVER, ADMITTED TO ICU AND THEN HOSPICE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
8,0
Labordaten
COVID TEST, CXR
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
nka
Vorherige Impfungen
-

VAERS 1443239

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

schwer
Staat
IL
Alter
14,0
Geschlecht
M
Eingang
02.07.2021
Impfdatum
09.06.2021
Beginn
28.06.2021
Tage bis Beginn
19,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Arrhythmia Chest pain Myocarditis Nausea Troponin increased

Symptomtext

myocarditis with troponin elevation and arrhythmias diagnosed 7/1/21 after episode of chest pain and nausea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
2,0
Labordaten
troponin 3.44 (ref range <0.045 ng/ml) at ED troponin 6.94 (ref range 0.00-0.09 ng/ml) troponin 5.36 (ref range 0.00-0.09 ng/ml)
Aktuelle Erkrankungen
n/a
Vorgeschichte
remote asthma history
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 1096709

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

schwer
Staat
VA
Alter
17,0
Geschlecht
F
Eingang
14.03.2021
Impfdatum
11.03.2021
Beginn
12.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Basophil percentage decreased Blood calcium normal Blood chloride normal Blood creatinine normal Blood glucose increased Blood culture negative Blood lactic acid Blood potassium normal Blood sodium normal Blood urea normal C-reactive protein increased Carbon dioxide normal Eosinophil percentage decreased Generalised tonic-clonic seizure Haematocrit normal Haemoglobin normal Condition aggravated Fatigue

Symptomtext

Severe, prolonged (>20min) seizure developed appr 27 hours after receipt of 1st Pfizer COVID vaccine. At the time of this seizure, she had a fever of 103F and was noted to be fatigued. She required intranasal versed and clonazepam to break the seizure, required supplemental oxygen and hospitalization.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
1,0
Labordaten
BMP: Na 139, K 3.6, Cl 104, CO2 23 BUN 12, Cr 0.66, Glu 124, Ca 9.0 Lacate 1.0 CBC: WBC 14.8, Hgb 13.9, Hct 40.1, Plt 342. 90.5% neutrophils, 4.5% lymphocytes, 4.7% monocytes, 0% eosinophils, 0.3% basophils, no bands ASAP SARS-CoV-2 Rapid: No pathogen detected Respiratory viral PCR panel - No viruses detected CRP 26 mg/L Blood culture obtained @1924 on 12MAR2021 - No growth to date Urine culture obtained @1700 on 12MAR2021 - Negative U/A with no leukocyte esterase or nitrites, 3 WBC per hpf
Aktuelle Erkrankungen
None
Vorgeschichte
Seizure disorder Cortical dysplasia Monosomy Xq26 and Trisomy 6p21.3 Autism Global developmental delay Overactive bladder Asthma
Andere Medikamente
Mirena IUD Briviact 10 mg/mL solution, 7 mL (70 mg) PO twice a day Miralax 1 capful daily PRN Midazolam 5 mg ? 1 mL per nostril, emergency medication for seizures Clonazepam 0.5 mg ? 1 tab under the tongue after 20 minutes of seizures Mupi
Allergien
Unasyn ? severe urticaria Oxcarbazepine 300 mg (Trileptal) ? skin rash, fever, leukopenia, elevated liver labs (was admitted for this)
Vorherige Impfungen
-

VAERS 1649211

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

moderat
Staat
IN
Alter
29,0
Geschlecht
F
Eingang
28.08.2021
Impfdatum
09.04.2021
Beginn
09.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper Back pain Breast pain Confusional state Diarrhoea Discomfort Fatigue Pain in extremity Tremor

Symptomtext

Severe soreness in breasts on day three; Severe soreness in breasts on day three (constant discomfort throughout day); Exhausted day 2 and 3; Stomach pain day 2; Diarrhea day 2; Back pain day 1, 2, 3; Foggy mental status day 1; Sore arm day 1 and two; Shaking immediately after vaccination; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09Apr2021 at 08:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative disk disease in low back (back pain unrelated to DDD), meat allergy and seafood allergy. Concomitant medications included sertraline hydrochloride (ZOLOFT), lorazepam (MANUFACTURER UNKNOWN), and lisdexamfetamine mesilate (VYVANSE), all for an unknown indication from an unknown start date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 19Mar2021 at 07:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation and also experienced drug allergy to cefalexin (KEFLEX). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021, the patient experienced shaking immediately after vaccination and also experienced foggy mental status day 1, sore arm day 1 and two and back pain day 1, 2, 3. On 10Apr2021, the patient experienced stomach pain day 2, diarrhea day 2 and exhausted day 2 and 3. On 11Apr2021, the patient experienced severe soreness in breasts on day three (constant discomfort throughout day). No therapeutic measures were taken as the result of adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the event severe soreness in breasts on day three (constant discomfort throughout day), back pain, foggy mental status, exhausted, stomach pain, diarrhea, shaking immediately after vaccination and sore arm were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Back pain ((back pain unrelated to DDD)); Degenerative disc disease (Degenerative Disk Disease in low back (back pain unrelated to DDD)); Meat allergy (meat (yes, really)); Seafood allergy
Andere Medikamente
ZOLOFT; LORAZEPAM; VYVANSE
Allergien
-
Vorherige Impfungen
-

VAERS 1647615

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

moderat
Staat
UT
Alter
28,0
Geschlecht
M
Eingang
28.08.2021
Impfdatum
22.01.2021
Beginn
24.01.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Chills Condition aggravated Cough Ear pain Oropharyngeal pain Pain SARS-CoV-2 test

Symptomtext

feeling body aches; chills; low energy; symptoms started getting worse; sharp pains in throat; sharp pains in ears; coughing; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old male patient received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration in Arm Left on 22Jan2021 15:00(age at vaccination: 28 Years) as SINGLE DOSE for covid-19 immunisation (at pharmacy). Patient didn't receive other vaccines within 4 weeks prior to vaccination. Medical history and concomitant medications were not reported. Patient had no allergies. Patient didn't had covid-19 prior to vaccination. On 24Jan2021 13:00 the patient experienced feeling body aches, chills, low energy, symptoms started getting worse, sharp pains in throat, sharp pains in ears, coughing. No therapeutic measures were taken for the events. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 05Feb2021 Covid test name post vaccination was Slava test. Patient was not tested to covid-19 to post vaccination. The outcome of the events pain, chills, asthenia, oropharyngeal pain, ear pain, cough was not recovered, the outcome of the event condition aggravated was unknown. Follow-up attempts completed. No further information expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Test Date: 20210205; Test Name: Slava test; Test Result: Negative ; Comments: Covid test name post vaccination=Slava test
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1329396

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

moderat
Staat
MD
Alter
-
Geschlecht
F
Eingang
19.05.2021
Impfdatum
17.04.2021
Beginn
01.04.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain

Symptomtext

The patient didn't have any medical conditions or medications that she is taking. It was reported that I am experiencing chest pains, is this normal? When I breath in it hurts in the left side of my chest. The event started on an Apr2021 with outcome of unknown. The event was reported as non-serious. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316250

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

moderat
Staat
-
Alter
-
Geschlecht
F
Eingang
14.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Migraine Pain

Symptomtext

On an unspecified date, approximately 14 hours after the 2nd dose, the patient experienced pain up and down her left side, the side of the shot. The next day, the patient had a migraine when standing up. Outcome of the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1132829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

moderat
Staat
ME
Alter
64,0
Geschlecht
F
Eingang
25.03.2021
Impfdatum
20.03.2021
Beginn
21.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Migraine Nausea Vomiting

Symptomtext

24 hours after receiving shot I experienced severe vomiting that occurred every 20 mins for the first 12 hours..every hour for the 2nd 12 hours and every couple of hours for the third set of 12 hours for a total of 36 hours. Unable to hold down even a drink of water. I suffer from migraines and had one during a 3 day span from Sunday until Tuesday evening 9 pm. Now a full 4 days from the vaccine I still have nausea and extreme fatigue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Migraines
Andere Medikamente
Levothyroxine 88mcg Sumatriptan 50mg Ibuprofen
Allergien
None
Vorherige Impfungen
-

VAERS 1082222

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Bnt162b2

moderat
Staat
MI
Alter
81,0
Geschlecht
M
Eingang
08.03.2021
Impfdatum
03.03.2021
Beginn
03.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Chest pain Electrocardiogram normal Paraesthesia Tongue disorder Troponin normal

Symptomtext

Tongue felt "thick", cheeks tingled, and he developed chest pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
1,0
Labordaten
normal EKG and negative serial troponins
Aktuelle Erkrankungen
no
Vorgeschichte
Coronary artery disease and prostate cancer
Andere Medikamente
aspirin 325 MG tablet atenolol (TENORMIN) 25 MG tablet cholecalciferol (VITAMIN D3) 1,000 unit tablet clopidogrel (PLAVIX) 75 mg tablet EPINEPHrine (EPIPEN) 0.3 mg/0.3 mL AtIn famotidine (PEPCID) 20 MG tablet furosemide (LASIX) 20 MG tablet
Allergien
Bee sting anaphylaxis Diazepam Narcotic antagonists
Vorherige Impfungen
-

VAERS 1067142

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

moderat
Staat
MN
Alter
60,0
Geschlecht
F
Eingang
02.03.2021
Impfdatum
09.02.2021
Beginn
12.02.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anti-cyclic citrullinated peptide antibody positive Antinuclear antibody Arthralgia Aspartate aminotransferase normal Blood creatine phosphokinase increased Blood creatine phosphokinase normal Blood creatinine normal C-reactive protein increased Chills Dysstasia Electrophoresis protein Erythema Gait disturbance Haemoglobin normal Hepatitis B core antibody positive Hepatorenal syndrome Mobility decreased N-terminal prohormone brain natriuretic peptide increased

Symptomtext

Vaccine given 2/9/21. On the afternoon of 2/12/21 I began to have joint pains in my right wrist. By 2/10/21 in the morning both elbows, knees and wrists were sore. Elbows and right knee felt warm to the touch. Nodules or red spots developed around the joints. I could barely walk or climb in and out of the car, the bed, and had a very difficult time standing up from the toilet or a low chair or couch. No fever, but did have a few chills with teeth chattering at least twice.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
2/19/2021: CRP 12.8, CK 77, NT pro-BNP 354. 2/24/21: WBC8.0, HGB 13.3, PLT 304, Sed Rate 37, CRP 17.8, AST 26, Creat 0.77,ANA 0.4, CCNP <15.6, RA factor <15, UA normal, SPEP No monoclonal protein. 3/1/21: SS-A/Ro Ab IgG, SS-B/LA, Sm Ab, RNP, Sc 170, Jo 1 Ab, Myeloperoxidase, proteinase 3, all were <0.2. ANA Hep2 substrate <1:80 (neg).
Aktuelle Erkrankungen
-
Vorgeschichte
Ventricular ectopy Hyperlipidemia History of stroke Obesity
Andere Medikamente
Amiodarone 400 mg daily Metoprolol succinate 75 mg daily Lisinopril 2.5 mg daily Venlafaxine 37.5 mg bid Atorvastatin 10 mg daily Preservision supplement bid Multivitamin 1 tab daily Vitamin D, 2000 units daily aspirin 81 mg daily
Allergien
Adhesives IVP contrast dye
Vorherige Impfungen
-

VAERS 1057259

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

moderat
Staat
IL
Alter
83,0
Geschlecht
F
Eingang
26.02.2021
Impfdatum
24.02.2021
Beginn
24.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injected limb mobility decreased Injection site pain Product administered at inappropriate site

Symptomtext

Really sore shoulder. Couldn?t raise my arm for two days and still hurts. SHOT WAS GIVEN TOO HIGH

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Restless leg
Vorgeschichte
Restless leg. Blood pressure, Thelasemia
Andere Medikamente
Blood pressure pills, vitamin D, melatonin, Ropinarole
Allergien
-
Vorherige Impfungen
-

VAERS 1329554

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
-
Alter
-
Geschlecht
M
Eingang
19.02.2022
Impfdatum
06.05.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Peripheral swelling Vaccination site pain

Symptomtext

Swelling under his arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. A 73 year-old male patient received bnt162b2 (BNT162B2), administration date 06May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "Swelling under his arm". Additional information: patient enquired was it a problem if he was on blood thinners. Reporter stated that, when vaccinating persons with increased bleeding risk, providers often avoid giving intramuscular injections (not just this vaccine) or choose alternative routes because of the risk for hematoma formation after injections. The Pfizer-BioNTech COVID-19 Vaccine can only be administered as an intramuscular injection. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021523838 same reporter/drug, different patient/event

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1988153

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

mild
Staat
-
Alter
-
Geschlecht
U
Eingang
29.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Myalgia

Symptomtext

left deltoid sore; This case was reported by a consumer via other manufacturer and described the occurrence of muscle soreness in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis and COVID 19 VACCINE PFIZER (batch number BNT162B2, expiry date unknown) for prophylaxis. On an unknown date, the patient received Shingrix, Influenza vaccine Quadrivalent unspecified season and COVID 19 VACCINE PFIZER. On an unknown date, less than a year after receiving Shingrix and Influenza vaccine Quadrivalent unspecified season, the patient experienced muscle soreness. On an unknown date, the outcome of the muscle soreness was unknown. It was unknown if the reporter considered the muscle soreness to be related to Shingrix and Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. Shingrix was the breeze. Been 2021 pincushion 3 vaccine of Pfizer Covid vaccine, Flu shot and now this Shingrix. But the patient left deltoid was sore .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myalgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1807468

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

mild
Staat
-
Alter
40,0
Geschlecht
F
Eingang
22.10.2021
Impfdatum
18.05.2021
Beginn
18.05.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Hypersensitivity Weight

Symptomtext

Headache; she has environmental allergies like pollen and has noticed, after the vaccines, they get severe; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. A 40-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was BNT162B2 and expiration date was not reported), via an unspecified route of administration, administered in left arm on 18May2021 at 11:00 (at the age of 40 year) as dose 2, single for covid-19 immunization. Medical history included pollen allergy. The patient's concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EWU175 and expiration date were not reported), via an unspecified route of administration, administered in left arm, on 29Apr2021 at 01:00 pm (at the age of 40 year) as dose 1, single for COVID-19 immunization and experienced Arm pain, Chills, really tired and really hungry the next day too which is not normal. On 18May2021, the headache started an hour after the second dose and lasted most of the day, until that evening. Patient took Tylenol, it was not a severe headache. The patient also explained that she has environmental allergies like pollen and has noticed, after the vaccines, they get severe on an unspecified date in 2021. They have stopped but there are times she feels they more severe now when she does get them, where they were light before the vaccines. The patient underwent lab tests and procedures which included weight with result 127-130 lbs. The outcome of event headache was recovered on an unspecified date in 2021 while for allergy aggravated was unknown. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101116643 similar report from same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
Test Name: Weight; Result Unstructured Data: Test Result:127-130 lbs
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Pollen allergy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1709087

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

mild
Staat
-
Alter
36,0
Geschlecht
F
Eingang
17.09.2021
Impfdatum
06.05.2021
Beginn
22.05.2021
Tage bis Beginn
16,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Balance disorder Fatigue Menstruation delayed Vertigo

Symptomtext

Extreme fatigue and then extreme vertigo. No balance at all. Also no period since injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Ent appointment July 14
Aktuelle Erkrankungen
-
Vorgeschichte
Osteoporosis
Andere Medikamente
N/a
Allergien
Dairy/ latex
Vorherige Impfungen
-

VAERS 1661411

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

mild
Staat
-
Alter
81,0
Geschlecht
U
Eingang
01.09.2021
Impfdatum
18.02.2021
Beginn
19.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Epistaxis Fatigue Pyrexia Rhinorrhoea Sinus congestion

Symptomtext

fatigue; fevers; runny nose; sinus congestion; bloody nose; This is a spontaneous report from a contactable Other HCP. This Other HCP reported for a patient that: An 81-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 18Feb2021 (at the age of 81-year-old) as single dose for covid-19 immunisation. Medical history included Has mild elevated Blood pressure from an unknown date and unknown if ongoing but does not take meds for it. Patient takes no medications. Patient received second dose of Pfizer BioNTech Covid 19 Vaccine on 18Feb2021 and began experiencing fatigue, fevers, runny nose, sinus congestion and had a bloody nose morning of 19Feb2021. All symptoms except bloody nose remain today (20Feb2021), but patient stated it was a little better today. Event took place after use of product. The outcome of the event bloody nose was reported as recovered on an unspecified date in Feb2021 and rest all other events were recovering. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure high (Patient takes no medications. Has mild elevated Blood pressure, but does not take meds for it.)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1647628

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

mild
Staat
-
Alter
-
Geschlecht
F
Eingang
28.08.2021
Impfdatum
01.01.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Facial pain Headache Hypoaesthesia Inflammation Swelling face

Symptomtext

headache; an inflamed right side of the face /it is swollen enough to be noticeable; Feeling Numb /I felt like my face was numb in a weird way; one part of her face seemed a little more inflamed; my face got in pain on the right side /it kind of feel like I had an anesthesia and it was wearing off; This is a spontaneous report from a contactable pharmacist (patient). A female patient of (Age:32, unit not provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date on Jan2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache, an inflamed right side of the face /it is swollen enough to be noticeable, feeling numb /i felt like my face was numb in a weird way, one part of her face seemed a little more inflamed, my face got in pain on the right side /it kind of feel like i had an anesthesia and it was wearing off on an unspecified date on 2021. The case was reported as non serious. Reported as, patient received the first dose of the Covid vaccine and states that she experienced the typical side effects of a headache, but also is experiencing "an inflamed right side of the face." She states that it was swollen enough to be noticeable and it feels as if she has received anesthesia and it was wearing off. She was scheduled to receive her second dose of the vaccine a day after. She was calling because she got the COVID vaccine a month ago on friday. She states that after she got it, a few hours later one, part of her face seemed a little more inflamed, and it felt like anesthesia was wearing off on one side. The feeling lasted a few days, and she felt it go down little by little. It took a few days to go away but I felt like my face was numb in a weird way. Not completely numb but just feel like coming off of anesthesia". Outcome of all the events were unknown. Follow-up attempts completed. No further information expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1582394

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
FL
Alter
14,0
Geschlecht
F
Eingang
18.08.2021
Impfdatum
30.06.2021
Beginn
11.07.2021
Tage bis Beginn
11,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cough Nasal congestion Oropharyngeal pain Rhinorrhoea Upper respiratory tract infection

Symptomtext

upper resp infection- dry cough, nasal congestion, rhinorrhea, and sore throat

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 1558460

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Bnt162b2

mild
Staat
MO
Alter
30,0
Geschlecht
F
Eingang
14.08.2021
Impfdatum
12.08.2021
Beginn
14.08.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lip swelling Swollen tongue Urticaria

Symptomtext

Swollen tongue and lips, hives all over abdomen, arms, and legs

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Bronchitis
Andere Medikamente
N/a
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1426231

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
NC
Alter
-
Geschlecht
F
Eingang
25.06.2021
Impfdatum
05.02.2021
Beginn
05.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

An unspecified age female patient received bnt162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Lot number and Expiration date: Unknown), dose 1 via an unspecified route of administration on 05Feb2021 as 1st dose, single for an COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 05Feb2021, the patient had experienced arm pain. She wants to know if she can take Tylenol. The outcome of event was unknown. Information on Lot /Batch Number has been requested. Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1335957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
IL
Alter
-
Geschlecht
F
Eingang
20.05.2021
Impfdatum
27.03.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity Skin disorder

Symptomtext

The patient reported that after her first dose, a little up her arm towards the back, not where they put the shot, she had a bump that hurt when she touched it. She further stated that it went away. The patient received the second dose on 17Apr2021. The clinical outcomes of a little up her arm towards the back she had a bump that hurt when she touched it were recovered on unspecified dates. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1329394

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
-
Alter
-
Geschlecht
F
Eingang
19.05.2021
Impfdatum
15.04.2021
Beginn
01.04.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Malaise Vomiting

Symptomtext

Medical history and concomitant medications were not reported. The reporter stated that her mom got her COVID shot yesterday and did not feel too well. The patient was throwing up and had a bad headache. The reporter inquired what the patient could take. The clinical outcomes of did not feel too well, throwing up and had a bad headache were unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1329273

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
LA
Alter
26,0
Geschlecht
F
Eingang
19.05.2021
Impfdatum
20.01.2021
Beginn
01.01.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Illness Pain Pyrexia SARS-CoV-2 test Vomiting

Symptomtext

The patient medical history and concomitant medications were not reported. It was reported that patient got the first dose of Pfizer vaccine on 20Jan2021 and yesterday, with a week from the dose, he don't think it was related but he basically woke up and ended up getting very sick having like 101 degrees fever, vomiting, body ache. And he was really serious about quarantining, patient was a teacher and we just teach virtually currently and he was very just like unsure about where he would have got-ten anything and patient was able to get a COVID test today but it's not a rapid test, so he haven't gotten his results. But he just kind of want to reach out as far as like getting his second dose if that was still like okay to do, if that has been seen in anybody else. patient feel much better today, he don't, he likely haven't had a fever, still just have like some fatigue, kind of like normal after being really sick. patient took a Tylenol and have no idea about LOT and expiration date. The outcome of the a week from the dose, woke up and ended up getting very sick, 101 degrees fever recovering and for vomiting and body ache was unknown and for the event fatigue was not recovered. information on the lot/batch number has been requested. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Test Name: fever; Result Unstructured Data: Test Result:101; Test Name: COVID test; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1153307

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
CT
Alter
50,0
Geschlecht
F
Eingang
19.05.2021
Impfdatum
31.03.2021
Beginn
31.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Fatigue Movement disorder Polymerase chain reaction Vaccination site pain COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

The patient was not pregnant. The patient medical history was not reported. Concomitant medication included ADVIL 12 HOUR (IBUPROFEN). There were no allergies to medications, food, or other products. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 31Mar2021 at 10:00 PM the patient had experienced Sore arm at injection site, Some chills in the night and very tired and slow moving today. No treatment was received in response to the adverse events. The patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was tested for COVID-19. On 15Mar2021, the patient had PCR test (Polymerase chain reaction) nasal Swab and resulted as positive. On 18Mar2021 and 20Mar 2021, the patient had PCR test nasal swab and resulted as Negative. On an unspecified date, the outcome of the events were recovering. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Test Date: 20210315; Test Name: PCR test; Result Unstructured Data: Test Result:Covid-19; Test Date: 20210318; Test Name: PCR test; Result Unstructured Data: Test Result:Covid-19; Test Date: 20210320; Test Name: PCR test; Result Unstructured Data: Test Result:Covid-19
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: No
Andere Medikamente
ADVIL 12 HOUR
Allergien
-
Vorherige Impfungen
-

VAERS 1320029

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
-
Alter
-
Geschlecht
M
Eingang
15.05.2021
Impfdatum
12.03.2021
Beginn
12.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling abnormal Muscle strain Pain in extremity

Symptomtext

The patient medical history and concomitant medications were not reported. On 12Mar2021 same day after vaccination of first dose, the patient started experiencing his arm feels painful, felt strain when he lifts this arm, felt like there is something inside the arm, but cannot describe it further. The patient asked if these lingering symptoms were reported as side effect to the vaccine and if he should consult a doctor for them. The patient received both the doses of vaccine. The outcome of the events was reported as unknown. No follow-up attempts are needed, information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316257

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
OH
Alter
-
Geschlecht
F
Eingang
14.05.2021
Impfdatum
15.04.2021
Beginn
01.04.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Diarrhoea Illness Nasopharyngitis Pyrexia

Symptomtext

The patient's medical history and concomitant medications were not reported. The patient reported that she was sick everyday after she took the first dose and experienced all of the symptoms like colds, fever, chills and diarrhea. The outcome of the events was not recovered. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316216

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
WV
Alter
93,0
Geschlecht
F
Eingang
14.05.2021
Impfdatum
26.04.2021
Beginn
01.04.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Nausea

Symptomtext

A female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 26Apr2021 at 10:00 (Batch/Lot number was not reported)(at the age of 93-year-old) as single dose for COVID-19 immunisation. Medical history included anaphylactic shock and blood cholesterol abnormal, both from an unknown date and unknown if ongoing and total knee replacement in 2009. Concomitant medications included simvastatin taken for blood cholesterol abnormal, start and stop date were not reported; furosemide (LASIX) taken for diuretic therapy, start and stop date were not reported and potassium taken for an unspecified indication, start and stop date were not reported. The patient reported that around on 26Apr2021 at 21:00 she experienced diarrhea. She said that she has had it 8-10 times, and she was just a little bit nauseous. The patient outcome of the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Anaphylactic shock; Blood cholesterol abnormal; Total knee replacement
Andere Medikamente
SIMVASTATIN; LASIX [FUROSEMIDE]; POTASSIUM
Allergien
-
Vorherige Impfungen
-

VAERS 1316213

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
-
Alter
74,0
Geschlecht
M
Eingang
14.05.2021
Impfdatum
01.05.2021
Beginn
02.05.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills

Symptomtext

The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient experienced chills on 02May2021, 24hours after the second dose but then it went away. The outcome of the event was recovered in May2021. No follow-up attempts are possible. information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021510504 Same reporter/drug, different patient/event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316181

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
OH
Alter
-
Geschlecht
F
Eingang
14.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Herpes zoster Musculoskeletal stiffness

Symptomtext

The consumer called on behalf of her daughter who received the first dose of the Pfizer-Biontech Covid19 vaccine, 2 weeks ago. The patient developed stiffness in her neck, and they thought maybe she had "pulled her back out" because she was experiencing pain on the right side of her back. The medical staff at the Clinic (also reported as urgent care (pending clarification), where she was seen, think that she's experiencing "shingles without the rash" and indicated that they'd had "a lot of people" present this way after vaccination. The patient will be having bloodwork done to confirm shingles and will know in the next 72 hours. The reporter asked if there had been reports of shingles following vaccination. The reporter indicated that she does not want her daughter to receive a second dose of vaccine. The outcome of events was unknown. Information about lot/batch number has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1309482

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
IA
Alter
27,0
Geschlecht
F
Eingang
12.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Herpes zoster Rash

Symptomtext

A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced a rash within 3 days of receiving the first shot of Pfizer Biontech COVID vaccine. Reporter said the physician thought it might be a resurface of shingles. Rash cleared subsequently without any further complications. The outcome of the event rash was recovered while unknown for the event shingles. No follow-up attempts are possible; information about lot/batch number cannot been obtained

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306150

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
TN
Alter
-
Geschlecht
M
Eingang
11.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

The patient's medical history and concomitant medications were not reported. Caller reporting adverse event with Pfizer Covid vaccine. She was surprised by all of this after the vaccine. Her brother had one and he was six years older than caller and it didn't phase him, only a sore arm. The outcome of the event was unknown. No follow-up attempts are needed; Information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306093

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
NY
Alter
-
Geschlecht
F
Eingang
11.05.2021
Impfdatum
28.04.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Contusion Lethargy Tenderness Vaccination site pain Vaccination site swelling

Symptomtext

A female patient (unspecified age) received the first dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Lot number and expiry date: unknown), via unspecified route on 28Mar2021 at single dose for COVID-19 immunization. On an unspecified date, the patient noticed that when she getting dressed that she had tenderness in a small area that appeared bruised on the bra line to her back on the opposite side from where she got her vaccination. The patient stated that area is small and tender appears to be a "black and blue". The patient also had also had some lethargy, injection site pain and swelling to her arm at the injection site which she understands are normal, but she asks is the bruised area normal. Second dose of vaccination for the patient was scheduled on 19May2021 (21 days apart). The patient did not receive any treatment for the events. Outcome of the events was unknown. The action taken in response to the event(s) for BNT162B2 was not applicable. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
-
Alter
-
Geschlecht
M
Eingang
11.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity

Symptomtext

A male patient received both doses of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown) via an unspecified route of administration on an unknown date (received second dose day before yesterday as per report) as a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included clopidogrel bisulfate (PLAVIX) as an anticoagulant therapy. After both doses, the patient experienced sore arm. Patient was unaware at the time of his injections that he should mention taking an anti-coagulant. The outcome of the event was recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PLAVIX
Allergien
-
Vorherige Impfungen
-

VAERS 1306057

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
GA
Alter
-
Geschlecht
M
Eingang
11.05.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity

Symptomtext

A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) dose 2 via an unspecified route of administration as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical Vaccine included first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The caller reported that his sons are 23 and 25. Caller reported that both of his sons received both doses of the Pfizer Covid-19 vaccine. Caller reported that his sons both had sore arms for about a day and that their pain went away immediately. The outcome of the event was recovered in 2021. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1305978

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

mild
Staat
-
Alter
-
Geschlecht
F
Eingang
11.05.2021
Impfdatum
19.04.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Erythema Peripheral swelling Pruritus Upper limb fracture

Symptomtext

A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and Expiration date was not reported), via an unspecified route of administration on 19Apr2021 as a single dose for COVID-19 immunization. The patients medical history and concomitant medications were not reported. On an unspecified date the patient states that on Sunday, her under armpit was painful. When she went to take a shower, it's hurting, and she examined it and it was swelling up a little. On Monday, the swelling got a little bigger. Last night, the swelling got hot. It's bigger this morning and hard and swollen and red and it's cracking and itchy. The patient did not receive any treatment for the event. The outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1289647

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

mild
Staat
CA
Alter
45,0
Geschlecht
F
Eingang
05.05.2021
Impfdatum
19.04.2021
Beginn
23.04.2021
Tage bis Beginn
4,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia C-reactive protein increased Injection site pain Insomnia Joint range of motion decreased Neck pain Pain Red blood cell sedimentation rate increased

Symptomtext

MODERATE PAIN STARTED IN LEFT ARM AT INJECTION SITE WITHIN 4.5 DAYS OF VACCINE BEING ADMINISTERED. PAIN PROGRESSIVELY WORSENED OVER THE NEXT TWO DAYS, TRAVELLING UP THE ARM TO THE LEFT SHOULDER AREA AND UP TO THE BASE OF THE NECK. BY APRIL 26, 2021 (ONE WEEK AFTER VACCINE ADMINISTRATION), I COULD NO LONGER MOVE MY LEFT ARM, MY RANGE OF MOTION WAS SEVERELY IMPACTED AND PAIN WAS INTENSE (I COULD NOT SLEEP OR FUNCTION NORMALLY). I VISITED DR. ON TUESDAY, APRIL 27, AND SHE PRESCRIBED CYCLOBENZAPRINE, A MUSCLE RELAXANT FOR THE PAIN. X-RAYS WERE TAKEN OF MY LEFT SHOULDER AND CERVICAL SPINE. THE PAIN PERSISTED FOR ANOTHER WEEK, UNTIL APPROX. MONDAY MAY 3, 2021 (WHILE STILL TAKING CYCLOBENZAPRINE).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
BLOOD TESTS RESULTS, AMONG OTHERS, INDICATED C-REACTIVE PROTEIN LEVELS OF 36.7 MG/L AND SEDIMENTATION RATE OF 29 MM/H. BLOOD TESTS CAME BACK ON APRIL 27, 2021.
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
Microgestin FE 1/20 (28)
Allergien
NONE
Vorherige Impfungen
-

VAERS 1238710

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

mild
Staat
CA
Alter
41,0
Geschlecht
F
Eingang
21.04.2021
Impfdatum
12.04.2021
Beginn
12.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature increased Chills Heart rate increased Pain

Symptomtext

Evening vaccination was given she experienced chills, body aches, temp-102 and heart rate greater than 150 bpm. Symptoms pretty much resolved next day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
None known
Vorherige Impfungen
-

VAERS 990485

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

mild
Staat
TX
Alter
59,0
Geschlecht
F
Eingang
01.02.2021
Impfdatum
31.12.2020
Beginn
12.01.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature Contusion Feeling hot Nausea Rash erythematous

Symptomtext

red rash; bruise; slight nausea; slight feeling of fever but temp registered normal; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number BNT162b2), at age of 59-year-old via an unspecified route of administration in left arm on 31Dec2020 11:00 at single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included levothyroxine sodium (SYNTHROID), valsartan, rosuvastatin (ROSUVASTATIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. The patient had no known allergies. The patient was not pregnant at Time of Vaccination. The patient experienced red rash, bruise, slight nausea, slight feeling of fever but temp registered normal on 12Jan2021 01:00 with outcome of recovering. The patient received topical antibiotic, diphenhydramine (BENADRYL) for treatment. The events resulted in doctor or other healthcare professional office/clinic visit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
Test Date: 20210112; Test Name: temp; Result Unstructured Data: Test Result:Normal; Comments: slight feeling of fever but temp registered normal
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
SYNTHROID; VALSARTAN; ROSUVASTATIN
Allergien
-
Vorherige Impfungen
-

VAERS 945984

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

mild
Staat
TX
Alter
51,0
Geschlecht
F
Eingang
15.01.2021
Impfdatum
21.12.2020
Beginn
21.12.2020
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypersensitivity Pruritus Throat irritation Tongue pruritus Vaccination site pruritus

Symptomtext

Slight allergic reaction; itchiness immediately after the injection in the injection area; itchiness spread to parts of patients body like the back of her throat and tongue; itchiness spread to parts of the patients body like the back of their throat and tongue; itching to the area of the leg, the face, the head; This is a spontaneous report from a contactable consumer (patient). The 51-year-old patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) intramuscular (upper left arm), on 21Dec2020, at a single dose, for COVID-19 immunization/ prophylaxis. Relevant medical history included root canal. The patient has no concomitant medications. The patient previously took thimerosal (preservative) and experienced allergy. Patient knows the vaccine is preservative free. The patient received the first dose on 21Dec2020. She had a slight allergic reaction where she experienced itchiness immediately after the injection in the injection area (itching in the arm) and the itchiness spread to parts of her body like the back of her throat, tongue, area of the leg, the face, the head. She took three Benadryl as treatment for these events. The patient recovered completely that same evening (on 21Dec2020) before she went to bed around 10 or 11 that night after her third Benadryl. She was due to go back to get her second dose between 11Jan2021 and 13Jan2021, next week. She is concerned about getting the second dose since she had somewhat of a reaction with the first dose. She had to have a root canal and she was taking an antibiotic which she clarifies as a Z-pack, azithromycin. States her last antibiotic pill is due to be taken on Monday, 11Jan2021. She was asking if she can get the second dose. She is also concerned about how she may react to the 2nd dose of the vaccine while taking Azithromycin. They were informed at work that the 2nd dose of the vaccine should be administered between days 21 and 23 after the first one. Information about lot/batch number has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Root canal procedure.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 945926

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

mild
Staat
SC
Alter
53,0
Geschlecht
F
Eingang
15.01.2021
Impfdatum
07.01.2021
Beginn
08.01.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Headache Insomnia Pain

Symptomtext

Chills; body ache; headache; insomnia; This is a spontaneous report from a contactable healthcare professional (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the right arm on 07Jan2021 16:00 at a single dose for COVID-19 immunization. Medical history included depression. Patient was not pregnant. Concomitant medication included duloxetine hydrochloride (CYMBALTA). The patient experienced chills, body ache, headache, insomnia on 08Jan2021 02:00. Outcome of the events was not recovered. No treatment was given for the adverse events. The reporter assessed the events as non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Information of lot/batch number has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Depression.
Andere Medikamente
CYMBALTA.
Allergien
-
Vorherige Impfungen
-

VAERS 2620369

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

gering
Staat
IN
Alter
67,0
Geschlecht
M
Eingang
24.04.2023
Impfdatum
29.09.2021
Beginn
05.10.2021
Tage bis Beginn
6,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Computerised tomogram spine abnormal General physical health deterioration Loss of employment Magnetic resonance imaging spinal abnormal Muscle spasms Muscular weakness Myelitis transverse Neuralgia Positron emission tomogram abnormal Sensory loss Wheelchair user

Symptomtext

Diagnosed with transverse myelitis, loss of sensation below rib cage, muscle weakness, leg spasms, nerve pain, cramps, currently in wheelchair. Progressive decline over course of a year resulting in loss of employment and financial hardship. Conventional treatments have been ineffective.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Computerised tomogram spine abnormal
Hospital-Tage
20,0
Labordaten
Multiple MRIs, CT scans, PET scans, most recently 4/12/2023.
Aktuelle Erkrankungen
Renal cell carcinoma metastasis to bone
Vorgeschichte
Renal cell carcinoma
Andere Medikamente
-
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 1316261

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
-
Alter
-
Geschlecht
F
Eingang
19.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Nasopharyngitis

Symptomtext

cold; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "unknown", described as "cold". Additional Information: The patient received first dose and wanted to reschedule her appointment for the second dose because she has a cold. She mentioned that not only her who got a cold and wanted to reschedule but there were 3 others in her household as well. She was advised to reach out to the vaccination site. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nasopharyngitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869834

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

gering
Staat
-
Alter
10,0
Geschlecht
M
Eingang
15.11.2021
Impfdatum
11.11.2021
Beginn
11.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Immunisation Incorrect product formulation administered Underdose

Symptomtext

On 11/11/2021 at approximately 1715 I RN Nurse Manager realized that additional doses of the COVID clinic would need to be mixed and drawn up for the remaining patients on the schedule. I went into the medication room to mix a vial of the COVID vaccine with normal saline as I had been taught to do earlier in the day with the Pharmacist. I opened the red bag of supplies to mix up the vaccine and only found one vial in the bag with a salmon colored top. Remembering that that the vaccine came in a vial with an orange top I believed this to be the vaccine and was looking for the diluent. Unable to locate some I called pharmacist and she informed me that I was fine to use normal saline from another source to mix the vaccine. I located another source of normal saline within the clinic and used it to mix 1.3ml of normal saline into the vial. After following the mixing instructions of inverting the initial vial 10x, added the diluent, removed 1.3ml of air, and then inverted the vial 10x to mix, I then drew up multiple syringes of 0.2ml RN adjunct professor and an MA each took two syringes to vaccinators who were waiting to administer the vaccine to patients. approximately 10-15 minutes later a colleague and I called pharmacist to ensure I knew how to properly dispose of the unused vaccine. It was during this conversation that I realized I had not used the COVID vaccine vial but had used the diluent vial and had mixed additional NACL into the diluent vial. I immediately asked who had received the last 4 doses, 3 of those patients were still in the building and 1 patient had left. I notified the parents of the 3 children who were still on the premises of the error that was made and apologized. I then asked if they would still like their child(ren) to receive the COVID vaccine tonight and the parents agreed. Those 3 children each received a dose after I went back into the med room and correctly mixed the vaccine. The children remained under observation for 15 minutes and were then discharged.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Immunisation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869819

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

gering
Staat
-
Alter
8,0
Geschlecht
M
Eingang
15.11.2021
Impfdatum
11.11.2021
Beginn
11.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product preparation issue Underdose

Symptomtext

At the end of the Pediatric COVID vaccine clinic on 11/11/2021 at approximately 1715 I, RN Nurse Manager of the Pediatric clinic, realized that additional doses of the COVID clinic would need to be mixed and drawn up for the remaining patients on the schedule. I went into the medication room to mix a vial of the COVID vaccine with normal saline as I had been taught to do earlier in the day with Pharmacist. I opened the red bag of supplies to mix up the vaccine and only found one vial in the bag with a salmon colored top. Remembering that that the vaccine came in a vial with an orange top I believed this to be the vaccine and was looking for the diluent. Unable to locate some I called the Pharmacist and she informed me that I was fine to use normal saline from another source to mix the vaccine. I located another source of normal saline within the clinic and used it to mix 1.3ml of normal saline into the vial. After following the mixing instructions of inverting the initial vial 10x, added the diluent, removed 1.3ml of air, and then inverted the vial 10x to mix, I then drew up multiple syringes of 0.2ml RN adjunct professor for the School of Nursing and MA each took two syringes to vaccinators who were waiting to administer the vaccine to patients. approximately 10-15 minutes later staff member and I called the Pharmacists to ensure I knew how to properly dispose of the unused vaccine. It was during this conversation that I realized I had not used the COVID vaccine vial but had used the diluent vial and had mixed additional NACL into the diluent vial. I immediately asked who had received the last 4 doses, 3 of those patients were still in the building and 1 patient had left. I notified the parents of the 3 children who were still on the premises of the error that was made and apologized. I then asked if they would still like their child(ren) to receive the COVID vaccine tonight and the parents agreed. Those 3 children each received a dose after I went back into the med room and correctly mixed the vaccine. The children remained under observation for 15 minutes and were then discharged.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869760

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

gering
Staat
-
Alter
6,0
Geschlecht
M
Eingang
15.11.2021
Impfdatum
11.11.2021
Beginn
11.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product preparation issue Underdose

Symptomtext

Patient received a 0.2ml injection of NACL instead of a 0.2ml injection of the COVID vaccine for 5-11 year-old patients. At the end of the COVID vaccine clinic on 11/11/2021 at approximately 1715 I, RN Nurse Manager of the clinic realized that additional doses of the COVID clinic would need to be mixed and drawn up for the remaining patients on the schedule. I went into the medication room to mix a vial of the COVID vaccine with normal saline as I had been taught to do earlier in the day with Pharmacist. I opened the red bag of supplies to mix up the vaccine and only found one vial in the bag with a salmon colored top. Remembering that that the vaccine came in a vial with an orange top I believed this to be the vaccine and was looking for the diluent. Unable to locate some I called pharmacist and she informed me that I was fine to use normal saline from another source to mix the vaccine. I located another source of normal saline within the clinic and used it to mix 1.3ml of normal saline into the vial. After following the mixing instructions of inverting the initial vial 10x, added the diluent, removed 1.3ml of air, and then inverted the vial 10x to mix, I then drew up multiple syringes of 0.2ml RN adjunct professor and MA each took two syringes to vaccinators who were waiting to administer the vaccine to patients. approximately 10-15 minutes later staff member and I called pharmacist to ensure I knew how to properly dispose of the unused vaccine. It was during this conversation that I realized I had not used the COVID vaccine vial but had used the diluent vial and had mixed additional NACL into the diluent vial. I immediately asked who had received the last 4 doses, 3 of those patients were still in the building and 1 patient had left. I notified the parents of the 3 children who were still on the premises of the error that was made and apologized. I then asked if they would still like their child(ren) to receive the COVID vaccine tonight and the parents agreed. Those 3 children each received a dose after I went back into the med room and correctly mixed the vaccine. The children remained under observation for 15 minutes and were then discharged. None of these children experienced any negative effects while under observation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869701

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

gering
Staat
KS
Alter
10,0
Geschlecht
M
Eingang
15.11.2021
Impfdatum
15.11.2021
Beginn
15.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product preparation issue

Symptomtext

At the end of the COVID vaccine clinic on 11/11/2021 at approximately 1715 I, RN Nurse Manager of the clinic realized that additional doses of the COVID clinic would need to be mixed and drawn up for the remaining patients on the schedule. I went into the medication room to mix a vial of the COVID vaccine with normal saline as I had been taught to do earlier in the day with Pharmacist. I opened the red bag of supplies to mix up the vaccine and only found one vial in the bag with a salmon colored top. Remembering that that the vaccine came in a vial with an orange top I believed this to be the vaccine and was looking for the diluent. Unable to locate some I called pharmacist and she informed me that I was fine to use normal saline from another source to mix the vaccine. I located another source of normal saline within the clinic and used it to mix 1.3ml of normal saline into the vial. After following the mixing instructions of inverting the initial vial 10x, added the diluent, removed 1.3ml of air, and then inverted the vial 10x to mix, I then drew up multiple syringes of 0.2ml RN and MA each took two syringes to vaccinators who were waiting to administer the vaccine to patients. approximately 10-15 minutes later another HCP and I called pharmacist to ensure I knew how to properly dispose of the unused vaccine. It was during this conversation that I realized I had not used the COVID vaccine vial but had used the diluent vial and had mixed additional NACL into the diluent vial. I immediately asked who had received the last 4 doses, 3 of those patients were still in the building and 1 patient had left. I notified the parents of the 3 patients who were still on the premises of the error that was made and apologized. I then asked if they would still like the patient to receive the COVID vaccine tonight and the parents agreed. Those 3 patients each received a dose after I went back into the med room and correctly mixed the vaccine. The patients remained under observation for 15 minutes and were then discharged. None of these patients experienced any negative effects while under observation. A phone call and message was left/sent to the parent of the 4th patient that night and the following morning another phone call was placed to the patient's father and the situation explained. Father agreed to bring the patient in on the following Monday in order to receive the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1833262

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT-162b2

gering
Staat
CA
Alter
43,0
Geschlecht
F
Eingang
01.11.2021
Impfdatum
05.10.2021
Beginn
08.10.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Full blood count Menometrorrhagia

Symptomtext

Pt reported metromenorrhagia starting 3 days post vaccination, prior to regular onset of menses, lasting 3 weeks . No hx of irregular or heavy menses reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Full blood count
Hospital-Tage
-
Labordaten
CBC pending, ordered 11/1/2021
Aktuelle Erkrankungen
none
Vorgeschichte
allergic rhinitis, chronic low back pain
Andere Medikamente
Prenatal vitamin, Mobic
Allergien
none known
Vorherige Impfungen
-

VAERS 1582308

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt-162b2

gering
Staat
FL
Alter
71,0
Geschlecht
M
Eingang
18.08.2021
Impfdatum
13.01.2021
Beginn
07.07.2021
Tage bis Beginn
175,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Chest X-ray Fall SARS-CoV-2 test

Symptomtext

increased weakness and multiple falls requiring hospitalization

Weitere VAERSDATA-Felder
Praegender Schweregrund
Asthenia
Hospital-Tage
7,0
Labordaten
CXR, covid test
Aktuelle Erkrankungen
-
Vorgeschichte
copd, SLEEP APNEA
Andere Medikamente
-
Allergien
nka
Vorherige Impfungen
-

VAERS 1567070

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge BNT162B2

gering
Staat
WY
Alter
69,0
Geschlecht
F
Eingang
15.08.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Accidental underdose Syringe issue

Symptomtext

Needle Hub Broke; liquid Dripped down Arm; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SYRINGE ISSUE (Needle Hub Broke) and ACCIDENTAL UNDERDOSE (liquid Dripped down Arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. BNT162B2) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced SYRINGE ISSUE (Needle Hub Broke) and ACCIDENTAL UNDERDOSE (liquid Dripped down Arm). On 02-Mar-2021, SYRINGE ISSUE (Needle Hub Broke) and ACCIDENTAL UNDERDOSE (liquid Dripped down Arm) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No Treatments were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1385542

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

gering
Staat
-
Alter
39,0
Geschlecht
F
Eingang
09.06.2021
Impfdatum
16.02.2021
Beginn
05.06.2021
Tage bis Beginn
109,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Abortion spontaneous

Symptomtext

Miscarriage @ 8 weeks gestation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abortion spontaneous
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1326185

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
-
Alter
-
Geschlecht
M
Eingang
18.05.2021
Impfdatum
09.04.2021
Beginn
19.04.2021
Tage bis Beginn
10,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19

Symptomtext

The patient's medical history and concomitant medications were not reported. On 19Apr2021, patient got Covid-19 symptoms and he tested Covid-19 positive on 21Apr2021. He said that he missed the 2nd dose and the vaccination facility called him for a follow-up. Patient also mentioned that he got a clearance letter and he is not contagious anymore. The outcome of the event was unknown. Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Test Date: 20210421; Test Name: COVID-19; Result Unstructured Data: Test Result:POSITIVE
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316248

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
NY
Alter
-
Geschlecht
M
Eingang
14.05.2021
Impfdatum
17.03.2021
Beginn
27.03.2021
Tage bis Beginn
10,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 SARS-CoV-2 test

Symptomtext

The patient received the first shot of Pfizer COVID-19 vaccine seven weeks ago. However, 10 days after getting the vaccine he got COVID. He had severe symptoms for week and a half but not to the point needed hospitalization. One week later he was clear and received a negative result. HE was clear now still have minor side effects. He did not feel comfortable getting the second dose of the vaccine at that time. He feel good enough to take the Pfizer COVID-19 vaccine but on him 49 day today. The patient asked the question would the vaccine be effective if he receive it 49 days after dose 1 and would it cause any danger to his health if he receive the vaccine this late. He went to get his vaccine, but they had some advisory at the clinic stating the vaccine could not be given later then 42 days after dose 1. The patient received first vaccine and 10 days later tested positive for Covid; symptoms afraid her because slight increased symptoms; it was dangerous, betrayed and it infected him. The patient stated, he had a very specific question to ask about the Pfizer Covid vaccine just for brief describe, he took the 1st dose of vaccine on 17Mar2021 and after 10 days later he tested positive for Covid and since then he thought recovering from Covid but now he betrayed, but symptoms afraid him, slight increases in symptoms when he had ever been want to go back to get his second shot or feel well enough to go back and get his second shot until now. The point was they gave him first shot and second shot was currently 49 days, was second shot still available for him or it was dangerous or it infected or was there another scenario that comes in private for research was there something secret. Patient was informed about Pfizer Medical information Department. Because it was on 10 days after the first dose, the time frame was significant in that probably the first dose had no impact to when that happening had it been three weeks before or 4 weeks before was probably medical value in that for what do or not, because he want to know if he can get the second shot that was more important if give him that number, would like to call that number. The patient underwent lab tests and procedures which included COVID test: positive (after getting the vaccine I got COVID) on 27Mar2021, negative (One week later I was clear and received a negative result) on Apr2021. The outcome of event was recovered on Apr2021. No follow-up attempts are possible. Information about lot/batch number has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Test Date: 20210327; Test Name: COVID; Test Result: Positive ; Comments: after getting the vaccine I got COVID; Test Date: 202104; Test Name: COVID; Test Result: Negative ; Comments: One week later I was clear and received a negative result.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316247

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
-
Alter
60,0
Geschlecht
F
Eingang
14.05.2021
Impfdatum
05.05.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
SARS-CoV-2 test Urinary tract infection

Symptomtext

A female patient received bnt162b2 (Pfizer- Biontech COVID-19 Vaccine Formulation: Solution for injection), via an unspecified route of administration on 05May2021 16:30 as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included eczema ( I have eczema, its since I was a baby) , food allergy, food allergy, drug hypersensitivity and food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced i had an uti on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on unspecified date. I have anaphylactic shock. Penicillin - not sure my reaction, I have eczema, its since I was a baby. I was told I was allergic to it, probably itching because of the eczema, I haven't drank orange juice in a long time, it makes me itchy, that's probably what the reaction to penicillin was. The outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
SARS-CoV-2 test
Hospital-Tage
-
Labordaten
Test Name: Covid-19 negative; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Eczema (Verbatim : I have eczema, its since I was a baby); Fruit allergy; Penicillin allergy; Seafood allergy; Shellfish allergy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316243

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
NY
Alter
-
Geschlecht
M
Eingang
14.05.2021
Impfdatum
06.04.2021
Beginn
18.04.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 SARS-CoV-2 test

Symptomtext

The patient's medical history and concomitant medications were not reported. It was reported that the patient got the first dose last 06Apr2021 and tested positive of Covid 19 last 18Apr2021. Second dose was on 16May (more than 21 days). The outcome of event was unknown. No follow-up attempts are needed. Information related to batch/lot number could not be requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Test Date: 20210418; Test Name: Covid-19; Result Unstructured Data: Test Result:Positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316228

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
-
Alter
-
Geschlecht
M
Eingang
14.05.2021
Impfdatum
26.03.2021
Beginn
06.04.2021
Tage bis Beginn
11,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 SARS-CoV-2 test SARS-CoV-2 test positive

Symptomtext

The patient medical history and concomitant medications were not reported. Patient was asked that, "I got my first vaccine on March 26th and then the following, on April 6th I tested positive for Covid. my second dose was supposed to be on April 16th but I was still positive. I was positive through April 23rd. I am no longer positive, What do I do with the second shot". The outcome of the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Test Date: 20210406; Test Name: SARS-CoV-2 test; Result Unstructured Data: Test Result:positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306103

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
-
Alter
19,0
Geschlecht
M
Eingang
11.05.2021
Impfdatum
16.04.2021
Beginn
19.04.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymphadenopathy

Symptomtext

A male patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 16Apr2021 (Lot number and Expiry date was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 16Apr2021, the patient had formed swollen nodes, a swollen kind of region above my left collar bone, patient can't really press into it, it was slightly sore when I press into it. Caller reported his experience after first dose. He recently had first dose on 16Apr2021 and since then well 3 days later he had formed swollen nodes, a swollen kind of region above his left collar bone? He can't really press into it was slightly sore when he pressed into it. Second dose was scheduled for 07May2021. Outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymphadenopathy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306074

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
NY
Alter
75,0
Geschlecht
M
Eingang
11.05.2021
Impfdatum
09.04.2021
Beginn
01.04.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Gingival abscess Gingival blister

Symptomtext

A male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced, he noticed a blister on the inside of his mouth on his gums in the front part of his mouth, he states that he punctured it and it drained blood and pus in Apr2021. Patient reported that a few days ago (apprx 25Apr2021) he noticed a blister on the inside of his mouth on his gums in the front part of his mouth. Patient stated that he punctured it and it drained blood and pus and, as of today 29Apr2021, it has resolved and he has no pain. He is going to the Dentist today to have it checked out and states he does not have a current MD to help address his symptom. He reports wearing a bridge. He provided his dentist's contact information. He wanted to know if this side effect could be from the vaccine. There was no PQC. The outcome of event was recovered on 29Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Gingival abscess
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306073

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
-
Alter
-
Geschlecht
F
Eingang
11.05.2021
Impfdatum
22.04.2021
Beginn
01.04.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site bruising

Symptomtext

A female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that "she still has bruising at the injection site" on Apr2021 with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306011

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge bnt162b2

gering
Staat
-
Alter
-
Geschlecht
F
Eingang
11.05.2021
Impfdatum
10.04.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Heavy menstrual bleeding

Symptomtext

A contactable female consumer (patient) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 10Apr2021 at a single dose for covid-19 immunization. The patient relevant medical history and concomitant medications were not reported. On an unknown date, the patient got her period, but her flow was heavier than normal. The outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Heavy menstrual bleeding
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1178819

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

gering
Staat
-
Alter
28,0
Geschlecht
F
Eingang
07.04.2021
Impfdatum
17.02.2021
Beginn
01.03.2021
Tage bis Beginn
12,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Ringing in ears on and off about every 3 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Asthma
Andere Medikamente
Multi vitamin
Allergien
Mepivicaine, pollen
Vorherige Impfungen
-

VAERS 1178624

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

gering
Staat
MT
Alter
58,0
Geschlecht
F
Eingang
07.04.2021
Impfdatum
19.03.2021
Beginn
19.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Joint stiffness Lymphadenopathy Musculoskeletal stiffness

Symptomtext

1. Severe hip STIFFNESS within 15 minutes, worsening over period of hours to involve low back, then over next day felt terrible stiffness throughout entire pelvis and adjacent joints; gradual improvement over 3 or 4 days, almost completely resolved, with some nagging reminders now and again, until today, with returning stiffness, like a flare up, lasting the entire day so far, along with severely heightened stiffness in finger joints. 2. SWOLLEN GLANDS at throat, most noticable beginning 4/1/2021, worse upon waking, and has gotten progressively worse each morning, now reminiscent of mumps (as a child). Settles down as day progresses. No sore throat or fever to report, however.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Joint stiffness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Polycythemia, fibromyalgia, macular dystrophy
Vorgeschichte
Fibromyalgia for 42 yrs
Andere Medikamente
Progesterone cream, restasis, diphenhydramine, phenylephrine
Allergien
Metals not including gold or stainless steel, environmental, seasonal, naproxen sodium
Vorherige Impfungen
-

VAERS 1123780

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162B2

gering
Staat
NJ
Alter
32,0
Geschlecht
F
Eingang
22.03.2021
Impfdatum
20.03.2021
Beginn
21.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Angioedema Swollen tongue

Symptomtext

EUA Pfizer-BioNtech vaccine patient presented to ER the next day following covid-19 immunization with angioedema. She experienced tongue swelling. Her airway is open and and patent and and she denies other allergic symptoms such as rash or pruritis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Angioedema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Garlic, Penicillins
Vorherige Impfungen
-

VAERS 1012906

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT162b2

gering
Staat
VA
Alter
56,0
Geschlecht
F
Eingang
08.02.2021
Impfdatum
29.01.2021
Beginn
05.02.2021
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blepharospasm Eyelid function disorder

Symptomtext

Significant left eye twitching, with involuntary eye closure for a second, that occurred every 3-10 minutes starting 2/5/21-2/8/21. Minimal occurrence on 2/8/21. Instructed to see hospital Ophthalmologist today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blepharospasm
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Tylenol
Allergien
Valuim
Vorherige Impfungen
-

VAERS 978130

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge BNT 162b2

gering
Staat
-
Alter
65,0
Geschlecht
M
Eingang
27.01.2021
Impfdatum
29.12.2020
Beginn
10.01.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Transient global amnesia

Symptomtext

transient global amnesia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Transient global amnesia
Hospital-Tage
-
Labordaten
went to ER
Aktuelle Erkrankungen
na
Vorgeschichte
Diabetes type 2, HTN, hyperlipidemia, asthma, anxiety
Andere Medikamente
-
Allergien
yellow food dye statin codeine aspartame
Vorherige Impfungen
-